• ELGi CEP modular compressed-air system for Australian manufacturing.
    ELGi CEP modular compressed-air system for Australian manufacturing.
Close×

ELGi has developed and is supplying its Customized Engineered Product (CEP), a modular, plug-and-play compressed-air system designed for flexible, decentralised manufacturing in Australia.

The system integrates a compressor, refrigerated or desiccant air dryer, air receiver tank, filtration system and an integrated control panel on a single steel skid. Each CEP package arrives fully assembled and factory-tested, ready for immediate connection and operation.

Modular design allows manufacturers to scale output as demand changes, operate skids independently to reduce downtime, minimise installation work and optimise energy use. Features including variable speed drive technology, optimised airflow and intelligent controls can deliver up to 35 per cent energy savings compared with fixed-speed systems, ELGi says.

All components are selected, assembled and tested by ELGi engineers to ensure consistent performance and simplified maintenance. The skid can be deployed quickly in remote or decentralised facilities, providing reliable compressed air without the need for a central compressor room.

The CEP range also supports sustainability objectives, enabling manufacturers to reduce energy consumption and CO2 emissions while lowering total cost of ownership through reduced maintenance and downtime.

Food & Drink Business

The Top 10 remained a stable list this year, with five companies holding their position – Fonterra (#1), JBS (#2), Coca-Cola Europacific Partners (#3), Asahi (#4), and Thomas Foods International (#7). The biggest change was Treasury Wine Estates dropping out of the list, from #10 to #13.

Food & Drink Business and IBISWorld present this year’s Top 100 companies, a ranking of Australia’s largest food and drink companies by revenue. This year reflects a sector positioning itself for immediate term viability and long-term competitiveness.

The surge in usage of ‘GLP-1’-style weight loss medications is seeing a “ripple effect” begin to unfold, impacting eating patterns in a number of countries around the world, Rabobank says in recently released research.